The efficiency of cross-linking methods in eradication of bacteria is influenced by the riboflavin concentration and the irradiation time of ultraviolet light

被引:21
作者
Backman, Anders [1 ]
Makdoumi, Karim [2 ,3 ]
Mortensen, Jes [4 ]
Crafoord, Sven [2 ,5 ]
机构
[1] Orebro Univ Hosp, Clin Res Ctr, SE-70185 Orebro, Sweden
[2] Orebro Univ Hosp, Dept Ophthalmol, SE-70185 Orebro, Sweden
[3] Orebro Univ Hosp, Ctr Hlth Care Sci, SE-70185 Orebro, Sweden
[4] Ryhov Cty Hosp, Dept Ophthalmol, Jonkoping, Sweden
[5] Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden
关键词
bacteria; cross-linking; exposure time; riboflavin; UVA; PATHOGEN REDUCTION; UV; KERATITIS; EFFICACY; TECHNOLOGY;
D O I
10.1111/aos.12301
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PurposeTo determine bacterial eradication using numerous riboflavin concentrations and different ultraviolet light A (UVA) radiant and exposure time in an experimental model. MethodsDilutions of Staphylococcus epidermidis were mixed with riboflavin at varying concentrations (0.007-0.09%). Effects on bacterial growth were evaluated after 0, 3, 6, 30 and 60min of UVA exposure (irradiance 30 and 3mW/cm(2)). Standard settings of UVA were compared with high-power UVA approach. Different fluid thicknesses of the exposed dilutions were also examined to improve the model. ResultsBacterial eradication (%) was increased after 60 compared with 30min of UVA exposure for concentrations of 0.03-0.07% but not for 0.09% riboflavin. There was a significant difference between the efficacy between 0.03 and 0.09% and eradication dropped from 80% to 50% (p=0.01). A correlation could be calculated for the amount of riboflavin at 60min of UVA and the ability to kill bacteria (p=0.01). The antibacterial effect was more pronounced when the tested bacterial suspension thickness was reduced. High-power UVA method was less potent in microbial elimination, eradicating only 60% of bacteria after 6min versus 97-99% after 60min in the low-power setting, compared with respective controls (p=0.02). ConclusionsIn these in vitro experiments, a longer UVA exposure time in combination with lower riboflavin levels were found to be favourable in killing bacteria as compared to the standard cross-linking settings. Further studies are needed to evaluate the clinical relevance of these findings.
引用
收藏
页码:656 / 661
页数:6
相关论文
共 24 条
[1]  
Al-Sabai N, 2010, Bull Soc Belge Ophtalmol, P13
[2]   Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products [J].
Goodrich, Raymond P. ;
Doane, Suzann ;
Reddy, Heather L. .
BIOLOGICALS, 2010, 38 (01) :20-30
[3]   Laboratory Measurement of the Absorption Coefficient of Riboflavin for Ultraviolet Light (365 nm) [J].
Iseli, Hans Peter ;
Popp, Max ;
Seiler, Theo ;
Spoerl, Eberhard ;
Mrochen, Michael .
JOURNAL OF REFRACTIVE SURGERY, 2011, 27 (03) :195-201
[4]   Riboflavin and Ultraviolet Light A Therapy as an Adjuvant Treatment for Medically Refractive Acanthamoeba Keratitis Report of 3 Cases [J].
Khan, Yasin A. ;
Kashiwabuchi, Renata T. ;
Martins, Suy Anne ;
Castro-Combs, Juan M. ;
Kalyani, Sachin ;
Stanley, Philip ;
Flikier, David ;
Behrens, Ashley .
OPHTHALMOLOGY, 2011, 118 (02) :324-331
[5]   ELECTROCHEMICAL PROPERTIES OF FLAVINS IN AQUEOUS-SOLUTIONS [J].
KSENZHEK, OS ;
PETROVA, SA .
BIOELECTROCHEMISTRY AND BIOENERGETICS, 1983, 11 (2-3) :105-127
[6]   Shifting Trends in Bacterial Keratitis in Toronto An 11-Year Review [J].
Lichtinger, Alejandro ;
Yeung, Sonia N. ;
Kim, Peter ;
Amiran, Maoz D. ;
Iovieno, Alfonso ;
Elbaz, Uri ;
Ku, Judy Y. F. ;
Wolff, Rachel ;
Rootman, David S. ;
Slomovic, Allan R. .
OPHTHALMOLOGY, 2012, 119 (09) :1785-1790
[7]   Infectious Keratitis Treated With Corneal Crosslinking [J].
Makdoumi, Karim ;
Mortensen, Jes ;
Crafoord, Sven .
CORNEA, 2010, 29 (12) :1353-1358
[8]   Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA) [J].
Makdoumi, Karim ;
Backman, Anders ;
Mortensen, Jes ;
Crafoord, Sven .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (02) :207-212
[9]   Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light [J].
Marschner, Susanne ;
Goodrich, Raymond .
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2011, 38 (01) :8-18
[10]   Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis [J].
Martins, Suy Anne R. ;
Combs, Juan Castro ;
Noguera, Guillermo ;
Camacho, Walter ;
Wittmann, Priscila ;
Walther, Rhonda ;
Cano, Marisol ;
Dick, James ;
Behrens, Ashley .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (08) :3402-3408